These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18728670)

  • 1. A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland.
    McDonald SA; Hutchinson SJ; Bird SM; Robertson C; Mills PR; Dillon JF; Goldberg DJ
    Br J Cancer; 2008 Sep; 99(5):805-10. PubMed ID: 18728670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage study.
    McDonald SA; Hutchinson SJ; Bird SM; Mills PR; Robertson C; Dillon JF; Williams T; Goldberg DJ
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):49-57. PubMed ID: 19773667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland.
    McDonald SA; Hutchinson SJ; Bird SM; Mills PR; Dillon J; Bloor M; Robertson C; Donaghy M; Hayes P; Graham L; Goldberg DJ
    Stat Methods Med Res; 2009 Jun; 18(3):271-83. PubMed ID: 19036907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).
    Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
    J Hepatol; 2016 Dec; 65(6):1086-1093. PubMed ID: 27569777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data linkage to monitor hepatitis C-associated end-stage liver disease and hepatocellular carcinoma inpatient stays in England.
    Ireland G; Simmons R; Hickman M; Harris R; Ramsay M; Sabin C; Mandal S
    J Viral Hepat; 2020 Jan; 27(1):20-27. PubMed ID: 31505083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea.
    Yi SW; Choi JS; Yi JJ; Lee YH; Han KJ
    Cancer; 2018 Jul; 124(13):2748-2757. PubMed ID: 29669170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
    Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
    J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study.
    Alavi M; Janjua NZ; Chong M; Grebely J; Aspinall EJ; Innes H; Valerio H; Hajarizadeh B; Hayes PC; Krajden M; Amin J; Law MG; George J; Goldberg DJ; Hutchinson SJ; Dore GJ
    J Viral Hepat; 2018 May; 25(5):473-481. PubMed ID: 29194861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality of those who attended drug services in Scotland 1996-2006: record-linkage study.
    Merrall EL; Bird SM; Hutchinson SJ
    Int J Drug Policy; 2012 Jan; 23(1):24-32. PubMed ID: 21719267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis.
    Miyakawa H; Izumi N; Marumo F; Sato C
    Alcohol Clin Exp Res; 1996 Feb; 20(1 Suppl):91A-94A. PubMed ID: 8659700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study.
    Amin J; Dore GJ; O'Connell DL; Bartlett M; Tracey E; Kaldor JM; Law MG
    J Hepatol; 2006 Aug; 45(2):197-203. PubMed ID: 16684579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
    Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?
    Elzouki AN; Eriksson S
    Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):989-94. PubMed ID: 8930564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.
    Tanaka H; Tsukuma H; Yamano H; Oshima A; Shibata H
    Int J Cancer; 2004 Dec; 112(6):1075-80. PubMed ID: 15386355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.
    Gjærde LI; Shepherd L; Jablonowska E; Lazzarin A; Rougemont M; Darling K; Battegay M; Braun D; Martel-Laferriere V; Lundgren JD; Rockstroh JK; Gill J; Rauch A; Mocroft A; Klein MB; Peters L
    Clin Infect Dis; 2016 Sep; 63(6):821-829. PubMed ID: 27307505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population.
    Haydon GH; Jarvis LM; Simmonds P; Harrison DJ; Garden OJ; Hayes PC
    Gut; 1997 Jan; 40(1):128-32. PubMed ID: 9155590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma.
    Hsu YC; Ho HJ; Wu MS; Lin JT; Wu CY
    Hepatology; 2013 Jul; 58(1):150-7. PubMed ID: 23389758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation.
    Hoffmann CJ; Subramanian AK; Cameron AM; Engels EA
    Transplantation; 2008 Sep; 86(6):784-90. PubMed ID: 18813102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.
    Lee MH; Yang HI; Lu SN; Jen CL; You SL; Wang LY; L'Italien G; Chen CJ; Yuan Y;
    Int J Cancer; 2014 Sep; 135(5):1119-26. PubMed ID: 24482200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.